A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Clinical trial NCT05884866 · COMPLETED

Trial details

NCT number: NCT05884866
Sponsor: Klinikum Nürnberg
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Renal Failure Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis Chronic Kidney Disease Stage 3 Electrolyte and Fluid Balance Conditions

Start date: 2023-07-13
Primary completion: 2025-12-29
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.